Puma Biotechnology (PBYI) EBITDA (2011 - 2026)
Puma Biotechnology's EBITDA came in at $10.1 million for Q2 2026, up 7.5% from $9.4 million a year earlier.
Powered by 
Analysis
Puma Biotechnology (PBYI) EBITDA (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Puma Biotechnology reported EBITDA of $40.92 million, down 28.6% year-over-year; for FY2025, it came in at $48.24 million, up 13.5% from FY2024.
- Going back by year, EBITDA was $42.49 million in FY2024 (-3.8%), $44.16 million in FY2023 (+31.6%), $33.56 million in FY2022 (+166.5%) and $12.6 million in FY2021.
- The five-year range for quarterly EBITDA is -$6.51 million (Q3 2021) to $24.96 million (Q3 2024).
- Year-over-year, EBITDA increased in three of the last five quarters, with growth averaging 17.6%.
- The fastest year-over-year change in EBITDA over five years came in Q1 2023 (growth of 323.6%), and the weakest in Q1 2022 (a decline of 92.6%).
- Business Quant data shows PBYI's EBITDA at -$1.24 million (Q1 2026), $19.76 million (Q4 2025) and $12.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Puma Biotechnology | 499.78 Mn | 112.42 Mn | 44.03 Mn | 10.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.10 Mn |
| Mar 31, 2026 | -1.24 Mn |
| Dec 31, 2025 | 19.76 Mn |
| Sep 30, 2025 | 12.30 Mn |
| Jun 30, 2025 | 9.40 Mn |
| Mar 31, 2025 | 6.78 Mn |
| Dec 31, 2024 | 16.21 Mn |
| Sep 30, 2024 | 24.96 Mn |
| Jun 30, 2024 | 729,000.00 |
| Mar 31, 2024 | 598,000.00 |
| Dec 31, 2023 | 17.69 Mn |
| Sep 30, 2023 | 11.46 Mn |
| Jun 30, 2023 | 7.77 Mn |
| Mar 31, 2023 | 7.24 Mn |
| Dec 31, 2022 | 12.47 Mn |
| Sep 30, 2022 | 4.86 Mn |
| Jun 30, 2022 | 14.52 Mn |
| Mar 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 9.81 Mn |
| Sep 30, 2021 | -6.51 Mn |
API Access
Puma Biotechnology EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();